| abstract |
Among others, the present invention relates to compounds comprising universal antibody binding moieties and targeting moieties. In some embodiments, the provided compounds recruit various types of antibodies against diseased cells such as cancer cells, and induce immune activities to kill such cells. The technologies provided are useful for treating various diseases including cancer. |